North America Cancer Gene Therapy Market Size & Outlook
North America cancer gene therapy market highlights
- The North America cancer gene therapy market generated a revenue of USD 1,704.3 million in 2024.
- The market is expected to grow at a CAGR of 20.2% from 2025 to 2030.
- In terms of segment, oncolytic virotherapy was the largest revenue generating therapy in 2024.
- Oncolytic Virotherapy is the most lucrative therapy segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2024 | USD 1,704.3 million |
| Market revenue in 2030 | USD 5,146.9 million |
| Growth rate | 20.2% (CAGR from 2025 to 2030) |
| Largest segment | Oncolytic virotherapy |
| Fastest growing segment | Oncolytic Virotherapy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncolytic Virotherapy |
| Key market players worldwide | Abeona Therapeutics Inc, Asklepios, Bluebird bio Inc, Celgene, Avidity Biosciences Inc Ordinary Shares, GlaxoSmithKline, Genelux Corp, Gen Digital Inc, Protagonist Therapeutics Inc, Merck KGaA, Onconetix Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 37.8% of the global cancer gene therapy market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 5,146.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Gene Therapy Market Scope
Cancer Gene Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Avidity Biosciences Inc Ordinary Shares | View profile | 253 | 10578 Science Center Drive, Suite 125, San Diego, CA, United States, 92121 | https://www.aviditybiosciences.com |
| Abeona Therapeutics Inc | View profile | 84 | 6555 Carnegie Avenue, 4th Floor, Cleveland, OH, United States, 44103 | https://www.abeonatherapeutics.com |
| Genelux Corp | View profile | 23 | 2625 Townsgate Road, Suite 230, Westlake Village, CA, United States, 91361 | https://www.genelux.com |
| Onconetix Inc | View profile | 12 | 201 East Fifth Street, Suite 1900, Cincinnati, OH, United States, 45202 | https://www.onconetix.com |
| Asklepios | View profile | 10001+ | Hamburg, Hamburg, Germany, Europe | https://www.asklepios.com/proresearch/ |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Celgene | View profile | 10001+ | Summit, New Jersey, United States, North America | https://www.bms.com |
| Bluebird bio Inc | View profile | 323 | 455 Grand Union Boulevard, Somerville, MA, United States, 02145 | https://www.bluebirdbio.com |
| Gen Digital Inc | View profile | 3400 | 60 E. Rio Salado Parkway, Suite 1000, Tempe, AZ, United States, 85281 | https://www.gendigital.com |
| Protagonist Therapeutics Inc | View profile | 124 | 7707 Gateway Boulevard, Suite 140, Newark, CA, United States, 94560 | https://www.protagonist-inc.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
North America cancer gene therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer gene therapy market will help companies and investors design strategic landscapes.
Oncolytic virotherapy was the largest segment with a revenue share of 100% in 2024. Horizon Databook has segmented the North America cancer gene therapy market based on oncolytic virotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to North America cancer gene therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America cancer gene therapy market databook
-
Our clientele includes a mix of cancer gene therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America cancer gene therapy market , including forecasts for subscribers. This continent databook contains high-level insights into North America cancer gene therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
